Nephrogenic Diabetes Insipidus: Lithium Links
What is Nephrogenic Diabetes Insipidus (NDI)?
Nephrogenic Diabetes Insipidus: Lithium Links Nephrogenic Diabetes Insipidus (NDI) is a rare kidney disorder that affects the body’s ability to regulate water balance. It is characterized by the inability of the kidneys to respond to a hormone called antidiuretic hormone (ADH) or vasopressin, which is responsible for reducing urine production and conserving water in the body.
In individuals with NDI, the kidneys fail to reabsorb sufficient water from the urine, resulting in the production of large volumes of diluted urine. This leads to excessive thirst (polydipsia) and increased urination (polyuria), causing dehydration and electrolyte imbalances if left untreated.
The condition can be either inherited (congenital) or acquired later in life. Congenital NDI is typically caused by genetic mutations that affect the function of the kidney tubules, where water reabsorption occurs. Acquired NDI, on the other hand, is often a result of certain medications, such as lithium, or underlying medical conditions that damage the kidneys.
While nephrogenic diabetes insipidus is a lifelong condition, it can be managed through various treatment strategies. These may include lifestyle modifications, such as drinking enough fluids to prevent dehydration, avoiding certain medications that worsen symptoms, and following a low-sodium diet to maintain electrolyte balance. In some cases, medications may be prescribed to enhance the kidney’s response to ADH.
It’s important for individuals with NDI to work closely with their healthcare providers to develop a personalized management plan that addresses their unique needs and minimizes the impact of the condition on their daily lives. Regular monitoring of kidney function and electrolyte levels is essential in maintaining optimal health and well-being for those living with nephrogenic diabetes insipidus.
The Link Between Lithium and Nephrogenic Diabetes Insipidus
Lithium, a widely used medication for bipolar disorder, has been found to be linked to the development of nephrogenic diabetes insipidus (NDI). NDI is a kidney disorder that affects the body’s ability to retain water, leading to excessive thirst and urination.
ACIBADEM Health Point: Your Health is Our Priority!
ACIBADEM Health Point, we are dedicated to providing exceptional healthcare services to our patients. With a team of highly skilled medical professionals and state-of-the-art facilities, we strive to deliver the highest standard of care to improve the health and well-being of our patients. What sets ACIBADEM Health Point apart is our patient-centered approach. We prioritize your comfort, safety, and satisfaction throughout your healthcare journey. Our compassionate staff ensures that you receive personalized care tailored to your unique needs, making your experience with us as seamless and comfortable as possible.The relationship between lithium and NDI is complex and involves multiple mechanisms. One such mechanism is the interference of lithium with the action of antidiuretic hormone (ADH), also known as vasopressin. ADH plays a crucial role in regulating water absorption in the kidneys. However, lithium disrupts this process, causing the kidneys to become less responsive to ADH.
In addition to its impact on ADH, lithium can also directly affect the renal tubules, which are responsible for reabsorbing water and electrolytes. This interference with the renal tubules further contributes to the development of NDI.
It is important to note that not everyone who takes lithium will develop NDI. The prevalence of NDI in individuals taking lithium varies, with some studies reporting rates as low as 15% and others as high as 60%. This variation can be attributed to factors such as the duration of lithium use, dosage, and individual susceptibility.
To mitigate the risk of NDI in individuals taking lithium, regular monitoring of kidney function is crucial. This includes periodic measurements of serum lithium levels and kidney function tests. Additionally, adjusting the lithium dosage or considering alternative medications may be necessary to manage NDI symptoms.
Factors Contributing to the Development of Lithium-Induced Nephrogenic Diabetes Insipidus
| Factors | Impact |
|---|---|
| Duration of lithium use | Longer duration increases the risk |
| Lithium dosage | Higher dosage increases the risk |
| Individual susceptibility | Some individuals are more prone to developing NDI |
Symptoms of Nephrogenic Diabetes Insipidus
Nephrogenic diabetes insipidus (NDI) is characterized by a range of symptoms that can significantly impact an individual’s daily life. The condition primarily affects the body’s ability to regulate water balance, resulting in excessive thirst, frequent urination, and diluted urine. While these hallmark symptoms are commonly observed in individuals with NDI, there are other potential indicators to be aware of as well.
Excessive thirst is one of the most prevalent symptoms of NDI. People with NDI often experience an intense and unquenchable thirst regardless of how much they drink. This can lead to increased fluid intake and frequent trips to the bathroom.
Excessive urination is another characteristic symptom of NDI. Individuals may find themselves urinating much more frequently than usual, even during the night. This can disrupt sleep patterns and cause inconvenience and discomfort.
Diluted urine is a notable sign of NDI. The urine produced by individuals with NDI tends to be clear and odorless, indicating that it is highly diluted. This occurs when the kidneys are unable to concentrate urine effectively, resulting in an excessive volume of urine.
In addition to these primary symptoms, there are other potential indicators of NDI that individuals may experience. These include:
- Dehydration: NDI can lead to dehydration due to the excessive loss of water through urine.
- Electrolyte imbalances: The disruption in water balance caused by NDI can also affect the levels of electrolytes in the body, leading to imbalances.
- Nocturia: Individuals with NDI may need to wake up multiple times during the night to urinate.
- Fatigue: Dehydration and frequent urination can contribute to feelings of fatigue and tiredness.
- Nausea: Some individuals with NDI may experience nausea, particularly if they become dehydrated.
If you or someone you know is experiencing these symptoms, it is important to consult a healthcare professional for proper diagnosis and management. Early detection and intervention can significantly improve the quality of life for individuals with NDI.
| Symptom | Description |
|---|---|
| Excessive thirst | An intense and unquenchable thirst regardless of fluid intake. |
| Excessive urination | Frequent and increased urination, including during the night. |
| Diluted urine | Clear, odorless urine due to the kidneys’ inability to concentrate urine effectively. |
| Dehydration | Loss of water through excessive urination leading to dehydration. |
| Electrolyte imbalances | Disruption of electrolyte levels in the body. |
| Nocturia | Waking up multiple times during the night to urinate. |
| Fatigue | Feelings of tiredness and exhaustion. |
| Nausea | Experience of nausea, particularly when dehydrated. |
Diagnosis and Management of Nephrogenic Diabetes Insipidus
Diagnosing nephrogenic diabetes insipidus (NDI) involves a comprehensive evaluation process to confirm the condition. A combination of tests and assessments is used to determine the underlying cause and establish an effective management plan. Additionally, managing NDI requires a multi-faceted approach that focuses on alleviating symptoms and addressing the underlying causes. Let’s explore the diagnosis and management strategies for nephrogenic diabetes insipidus.
Diagnostic Process
The diagnosis of nephrogenic diabetes insipidus begins with a thorough examination of medical history and a comprehensive physical examination. This helps identify any identifiable causes or underlying conditions contributing to the development of NDI. To confirm the diagnosis, various tests and evaluations are undertaken:
- Water Deprivation Test: This test measures urine concentration before and after water restriction. A decrease in urine concentration indicates impaired kidney function.
- Fluid Deprivation Test: In this test, patients are monitored for changes in urine output and osmolality after fluid restriction.
- Blood Tests: Blood tests help assess electrolyte levels, kidney function, and hormone levels associated with water balance.
- Genetic Testing: Genetic testing may be conducted to identify inherited forms of NDI.
- Renal Imaging: Imaging studies such as ultrasounds and MRIs can provide valuable insights into the structure and function of the kidneys.
Management Strategies
The management of nephrogenic diabetes insipidus aims to alleviate symptoms, maintain adequate fluid balance, and prevent complications. The following strategies are commonly employed:
- Fluid Intake: Maintaining proper hydration is essential for individuals with NDI. Ensuring an adequate intake of fluids, especially during hot weather or physical activities, helps compensate for excessive urine output.
- Dietary Modifications: Adjusting dietary intake, particularly reducing the consumption of foods and drinks that can trigger excessive thirst, can help manage NDI symptoms.
- Medications: Certain medications, such as thiazide diuretics and nonsteroidal anti-inflammatory drugs, can help improve kidney response and reduce urine output in some individuals with NDI.
- Hormone Replacement Therapy: Depending on the underlying cause of NDI, hormone replacement therapy may be necessary. This involves administering medications like desmopressin to supplement the hormones responsible for regulating water balance.
- Regular Monitoring: Close monitoring of fluid intake, urine output, and electrolyte levels is essential. Periodic check-ups and follow-up visits with healthcare providers aid in assessing the effectiveness of the management plan and making necessary adjustments.
| Management Strategies for Nephrogenic Diabetes Insipidus | Benefits | Considerations |
|---|---|---|
| Fluid Intake | Prevents dehydration and maintains fluid balance | Requires consistent monitoring of fluid intake and output |
| Dietary Modifications | Eases symptoms and minimizes excessive thirst | May require dietary restrictions and lifestyle adjustments |
| Medications | Reduces urine output and improves kidney response | Side effects and individual response may vary |
| Hormone Replacement Therapy | Supplements deficient hormones, improving water balance | Requires monitoring and dosage adjustments |
| Regular Monitoring | Ensures effective management and early detection of complications | Requires regular medical check-ups and follow-up visits |
It is important to consult with healthcare professionals specialized in endocrinology and nephrology for accurate diagnosis and personalized management plans for nephrogenic diabetes insipidus. By utilizing a comprehensive approach, individuals with NDI can effectively manage their condition and improve their quality of life.
Lithium-Induced Nephrogenic Diabetes Insipidus Mechanism
Understanding how lithium induces nephrogenic diabetes insipidus (NDI) requires a closer look at the effects of lithium on the kidneys and the disruption it causes to the regulation of water balance.
Lithium is a commonly used medication for mood disorders such as bipolar disorder. While it can be effective in managing these conditions, it can also have adverse effects on kidney function, leading to the development of NDI in some individuals.
The mechanism behind lithium-induced NDI involves its impact on the renal tubules, specifically the collecting ducts. Normally, antidiuretic hormone (ADH), also known as vasopressin, acts on the collecting ducts to increase water reabsorption, reducing urine output. However, lithium interferes with this process.
Research suggests that lithium affects the aquaporin-2 (AQP2) channels in the collecting ducts. AQP2 channels play a crucial role in water reabsorption. By downregulating AQP2 expression and impairing its function, lithium disrupts the normal water reabsorption process, leading to excessive urine production and the characteristic polyuria seen in NDI.
Lithium-induced NDI is categorized as nephrogenic, meaning it originates from the kidneys. Unlike central diabetes insipidus, where the issue lies in the secretion of ADH by the hypothalamus or its release by the pituitary gland, nephrogenic diabetes insipidus occurs due to the kidneys’ inability to respond properly to ADH.
The precise molecular mechanisms by which lithium affects AQP2 channels are not fully understood. However, it is believed that lithium alters the intracellular signaling pathways involved in AQP2 regulation, leading to its dysfunction. In addition, lithium may contribute to oxidative stress and inflammation in the kidneys, further impairing water reabsorption.
Impact on Water and Electrolyte Balance
Due to the disruption of water reabsorption caused by lithium-induced NDI, affected individuals experience increased urine output, resulting in polyuria. This excessive urine production can lead to dehydration if not managed properly. Furthermore, the body’s ability to regulate electrolyte balance, particularly sodium levels, may also be compromised.
In some cases, the electrolyte imbalances caused by lithium-induced NDI can lead to symptoms such as excessive thirst (polydipsia), electrolyte disturbances, and even kidney dysfunction. Regular monitoring of kidney function and electrolyte levels is essential for individuals on long-term lithium therapy.
The management of lithium-induced NDI involves a combination of strategies aimed at alleviating symptoms, preventing complications, and ensuring adequate hydration. This may include lifestyle modifications such as increasing fluid intake, dietary adjustments, and medication adjustments in consultation with healthcare professionals.
It is crucial for individuals taking lithium to be aware of the potential risk of developing nephrogenic diabetes insipidus and to monitor their kidney function closely. Regular check-ups and open communication with healthcare providers can help identify any early signs of NDI and allow for prompt intervention.
Treatment Options for Lithium-Induced Nephrogenic Diabetes Insipidus
Nephrogenic diabetes insipidus (NDI) caused by lithium usage requires careful management to alleviate symptoms and minimize long-term complications. Treatment options for individuals with lithium-induced NDI include medication, lifestyle modifications, and other interventions.
Medication
Medication is commonly prescribed to manage NDI symptoms and improve water balance in the body. The following medications may be used:
- Thiazide diuretics: These medications help reduce urine production and increase water reabsorption in the kidneys.
- Nonsteroidal anti-inflammatory drugs (NSAIDs): Some NSAIDs, such as indomethacin, can help reduce urine production and improve response to antidiuretic hormone (ADH).
- Amiloride: This medication helps decrease urine production by blocking sodium channels in the kidneys.
It is essential to work closely with a healthcare professional to determine the most suitable medication and dosage for each individual.
Lifestyle Modifications
Modifying certain lifestyle factors can also aid in managing lithium-induced NDI:
- Fluid intake regulation: Adjusting fluid intake levels can help maintain water balance and reduce excessive thirst and urination.
- Dietary adjustments: Limiting sodium intake and avoiding excessive intake of potassium can help regulate kidney function and fluid retention.
- Regular monitoring: Regular monitoring of urine volume, urine concentration, and blood electrolyte levels can provide valuable insights into the effectiveness of treatment and guide necessary adjustments.
Other Interventions
In severe cases of lithium-induced NDI, additional interventions may be required:
- Desmopressin: This synthetic form of antidiuretic hormone (ADH) can be administered in some cases to compensate for the impaired response to ADH in the kidneys.
- Underlying condition treatment: Identifying and treating the underlying cause of lithium-induced NDI, such as renal disease or electrolyte imbalances, may improve symptoms and outcomes.
It is crucial for individuals with lithium-induced NDI to work closely with their healthcare team to develop a comprehensive treatment plan tailored to their specific needs. Regular monitoring and adjustments may be necessary to optimize symptom management and maintain overall kidney health.
| Treatment Options | Benefits | Considerations |
|---|---|---|
| Medication | – Reduces urine production – Improves water reabsorption | – Requires ongoing monitoring and dosage adjustments – Potential side effects |
| Lifestyle Modifications | – Regulates fluid intake – Helps maintain water balance | – Requires adherence to dietary restrictions – Regular monitoring of fluid intake |
| Other Interventions | – Provides additional hormonal support – Addresses underlying conditions | – May have specific contraindications – Requires close medical supervision |
Kidney Implications of Lithium Usage
Long-term usage of lithium, a commonly prescribed medication for bipolar disorder, can have potential implications on kidney health. The sustained intake of lithium can lead to various renal complications and increase the risk of developing kidney disorders. Understanding these kidney implications is crucial for individuals on long-term lithium therapy.
1. Lithium Toxicity and its Impact on the Kidneys
Prolonged exposure to high levels of lithium in the blood can result in lithium toxicity, which affects multiple organs, including the kidneys. Lithium toxicity can lead to oxidative stress and cellular damage in the kidneys, impairing their normal functioning. The accumulation of lithium in renal tubules can further disrupt water and electrolyte balance, impacting kidney health.
2. Lithium-Associated Renal Complications
Chronic lithium use has been linked to several renal complications, such as nephrogenic diabetes insipidus (NDI), a condition where the kidney’s ability to concentrate urine is impaired. NDI associated with lithium usage, known as lithium-induced NDI, can cause excessive thirst, increased urination, and electrolyte imbalances.
In addition to NDI, other renal complications related to long-term lithium usage include chronic tubulointerstitial nephritis, chronic kidney disease (CKD), and end-stage renal disease (ESRD). These complications can culminate in irreversible kidney damage if not properly managed and monitored.
3. Lithium-Induced Kidney Disorder: A Pervasive Concern
Lithium-induced kidney disorder encompasses a spectrum of renal conditions resulting from long-term lithium usage. This disorder encompasses NDI, tubular dysfunction, and structural kidney damage, among other manifestations. The development of lithium-induced kidney disorder is influenced by various factors, including the dosage, duration of lithium therapy, and individual susceptibility.
It is essential for healthcare providers to closely monitor kidney function in individuals taking lithium, using regular blood tests and urine analysis. Early detection of kidney complications can enable timely intervention and reduce the risk of irreversible kidney damage.
4. Management of Kidney Implications
Managing the kidney implications of long-term lithium usage involves a multi-faceted approach. Careful monitoring of kidney function through regular check-ups and laboratory tests is crucial. This allows healthcare professionals to adjust lithium dosage, consider alternative medications, and provide necessary interventions to minimize renal complications.
Lifestyle modifications such as maintaining adequate hydration, adopting a balanced diet, and avoiding excessive sodium intake can also help support kidney health in individuals taking lithium.
Ultimately, a collaborative effort between patients, psychiatrists, and nephrologists is key to effectively managing the kidney implications associated with long-term lithium usage.
Lithium-Induced Polyuria: Understanding the Aquaretic Effect of Lithium
When it comes to the usage of lithium, one of the key side effects that individuals may experience is lithium-induced polyuria. Polyuria refers to the increased production of urine, and this phenomenon can be attributed to the aquaretic effect of lithium on the kidneys.
Lithium affects water reabsorption in the kidneys, leading to a disruption in the normal balance of fluid regulation within the body. Normally, the kidneys play a crucial role in reabsorbing water and concentrating urine to maintain appropriate hydration levels. However, the introduction of lithium can interfere with this process, causing water to be excreted in larger quantities through urine production.
This excessive urine production can result in symptoms such as increased frequency of urination, a constant feeling of thirst, and diluted urine. Individuals may find themselves needing to urinate more frequently, which can disrupt daily activities and sleep patterns. Additionally, the increased urine production often leads to persistent feelings of thirst as the body tries to compensate for the loss of water.
While the aquaretic effect of lithium-induced polyuria can be challenging to manage, there are strategies that individuals can implement to cope with these symptoms. Staying well-hydrated by drinking plenty of fluids throughout the day is essential to counteract the increased urine production. It is important to consult with a healthcare professional to determine the appropriate fluid intake based on individual needs.
In some cases, healthcare providers may also consider adjusting the lithium dosage or exploring alternative medications to minimize the aquaretic effect. Regular monitoring of kidney function and fluid-electrolyte balance becomes imperative to ensure optimal management of both lithium-induced polyuria and the underlying condition it relates to.
| Strategies for Managing Lithium-Induced Polyuria: |
|---|
| 1. Stay well-hydrated by drinking enough fluids throughout the day. |
| 2. Consult with a healthcare professional to determine the appropriate fluid intake based on individual needs. |
| 3. Regularly monitor kidney function and fluid-electrolyte balance. |
| 4. Consider adjusting the lithium dosage or exploring alternative medications under medical supervision. |
By understanding the aquaretic effect of lithium and implementing appropriate management strategies, individuals can navigate the challenges posed by lithium-induced polyuria while still achieving the therapeutic benefits of their medication.
Managing Nephrogenic Diabetes Insipidus in the Context of Lithium Use
When it comes to managing nephrogenic diabetes insipidus (NDI) in individuals who are also taking lithium, a comprehensive approach is key. NDI, a condition characterized by the kidneys’ inability to concentrate urine properly, can be exacerbated by lithium usage. To ensure optimal management and minimize symptoms and complications, regular monitoring, medication adjustments, and lifestyle modifications are crucial.
Regular Monitoring
Regular monitoring is essential for individuals with NDI and lithium use. This involves regular visits to a healthcare professional to assess kidney function, hormone levels, and overall health. By closely monitoring the condition, healthcare providers can make informed decisions regarding treatment and medication adjustments.
Medication Adjustments
Medication adjustments are often necessary in managing NDI in the context of lithium use. Healthcare providers may need to modify the dosage or switch to alternative medications to minimize the impact on kidney function. Finding the right balance requires careful consideration and collaboration between the individual and their healthcare team.
Lifestyle Modifications
Lifestyle modifications play a vital role in managing NDI. Individuals should maintain a well-balanced diet, ensuring adequate fluid intake while avoiding excessive salt and caffeine consumption. It is important to work with a dietitian to develop a personalized meal plan that supports overall kidney health.
In addition to dietary adjustments, it is crucial to maintain a proper hydration routine. This involves regularly drinking water throughout the day to prevent dehydration while avoiding excessive fluid intake, which can further exacerbate NDI symptoms.
| Tips for Managing NDI in Combination with Lithium Use |
|---|
| 1. Stay hydrated by drinking water regularly throughout the day. |
| 2. Avoid excessive consumption of salt and caffeine. |
| 3. Follow a well-balanced diet recommended by a dietitian. |
| 4. Regularly monitor kidney function and hormone levels with healthcare professionals. |
| 5. Collaborate with healthcare providers to adjust medication dosage or explore alternative options. |
By implementing these management strategies, individuals with NDI can lead fulfilling lives while effectively managing their condition in the context of lithium use. It is essential to maintain open communication with healthcare providers to address any concerns and ensure ongoing support throughout the treatment journey.
Conclusion
To summarize, this article has explored the connection between lithium usage and nephrogenic diabetes insipidus (NDI). NDI is a condition that disrupts the kidneys’ ability to regulate water balance, leading to symptoms such as excessive thirst, excessive urination, and diluted urine.
Research indicates that lithium, a commonly prescribed medication for bipolar disorder, can induce NDI in some individuals. The mechanisms by which lithium contributes to NDI involve its effects on the kidneys’ water reabsorption process.
If you are taking lithium, it is crucial to closely monitor your kidney health and seek medical guidance. Regular check-ups and medication adjustments can help manage symptoms and prevent complications associated with lithium-induced NDI. Additionally, lifestyle modifications such as adequate fluid intake and a balanced diet can support kidney function.
Remember, it is essential to prioritize your kidney health while taking lithium. If you experience symptoms of NDI or have concerns, consult with your healthcare provider to ensure proper management and support.
FAQ
What is nephrogenic diabetes insipidus (NDI)?
Nephrogenic diabetes insipidus (NDI) is a condition characterized by the kidneys' inability to concentrate urine, leading to excessive thirst and urine production. It occurs when the kidneys fail to respond to antidiuretic hormone (ADH) properly.
What is the link between lithium and nephrogenic diabetes insipidus?
Lithium usage has been linked to the development of nephrogenic diabetes insipidus (NDI) in some individuals. It is believed that lithium interferes with the kidney's ability to respond to ADH, leading to NDI in susceptible individuals.
What are the symptoms of nephrogenic diabetes insipidus?
The common symptoms of nephrogenic diabetes insipidus include excessive thirst (polydipsia), excessive urination (polyuria), and diluted urine. Other symptoms may include dehydration, fatigue, and electrolyte imbalances.
How is nephrogenic diabetes insipidus diagnosed and managed?
Nephrogenic diabetes insipidus is diagnosed through various tests, including a water deprivation test and a urine concentration test. Management strategies for NDI may involve medications to improve urine concentration, lifestyle modifications to reduce fluid intake, and close monitoring of kidney function.
What is the mechanism behind lithium-induced nephrogenic diabetes insipidus?
The exact mechanism by which lithium induces nephrogenic diabetes insipidus is not fully understood. However, it is believed that lithium disrupts the water balance in the kidneys, preventing them from properly responding to ADH and concentrating urine.
What are the treatment options for lithium-induced nephrogenic diabetes insipidus?
The treatment options for individuals with lithium-induced nephrogenic diabetes insipidus may include medication adjustments, such as reducing or discontinuing lithium, and using medications that enhance urine concentration. Fluid restriction and dietary modifications may also be recommended.
What are the kidney implications of lithium usage?
Long-term lithium usage can have various kidney implications, including lithium toxicity and the development of renal complications. Chronic lithium use has been associated with the development of kidney disorders, such as chronic kidney disease and tubulointerstitial nephritis.
How does lithium induce polyuria?
Lithium induces polyuria by affecting the kidneys' ability to reabsorb water. It interferes with the renal tubules' reabsorption of water, leading to increased urine production and the aquaretic effect.
How can nephrogenic diabetes insipidus be managed in the context of lithium use?
Managing nephrogenic diabetes insipidus in individuals who are also taking lithium involves regular monitoring of kidney function, adjusting lithium dosages if needed, and implementing lifestyle modifications to minimize symptoms and kidney complications.
ACIBADEM Healthcare Group Hospitals and Clinics
With a network of hospitals and clinics across 5 countries, including 40 hospitals, ACIBADEM Healthcare Group has a global presence that allows us to provide comprehensive healthcare services to patients from around the world. With over 25,000 dedicated employees, we have the expertise and resources to deliver unparalleled healthcare experiences. Our mission is to ensure that each patient receives the best possible care, supported by our commitment to healthcare excellence and international healthcare standards. Ready to take the first step towards a healthier future? Contact us now to schedule your Free Consultation Health session. Our friendly team is eager to assist you and provide the guidance you need to make informed decisions about your well-being. Click To Call Now!*The information on our website is not intended to direct people to diagnosis and treatment. Do not carry out all your diagnosis and treatment procedures without consulting your doctor. The contents do not contain information about the therapeutic health services of Acıbadem Health Group.
